Related Topics
Francisco Ruiz is bringing his truth to national HIV/AIDS policy
Francisco Ruiz, DrPH ’25, is drawing on his lived experiences in his work on national HIV/AIDS policy.
Once a malaria patient, student now has sights set on stopping the deadly disease
Cyrianne Keutcha, PhD ’25, has been around malaria all her life, from growing up in a malaria-endemic country, to being infected herself, and now to studying the parasite in the lab.
Op-ed: HIV prevention, treatment programs in South Africa leave older adults behind
South Africa needs to adapt its HIV prevention and treatment programs to better meet the needs of an older population.
A powerful methodology to guide health decision-making
Launched in 2021, CAUSALab brings together 14 epidemiology faculty members across multiple universities to collaborate on applying causal inference methods to compare the effectiveness and safety of health and policy interventions in a broad range of areas.
Botswana lab known for identifying Omicron variant receives new recognition
When the lab of the Botswana Harvard AIDS Institute Partnership produced the first genetic sequence of the Omicron variant of the coronavirus in fall 2021, the world took notice. More recognition came last month when the lab was…
New treatment for children with HIV shows promise
Roger Shapiro, professor of immunology and infectious diseases, discusses his recent study of a new treatment option for children living with HIV.
Social support may help young adults living with HIV maintain viral suppression
Katherine Tassiopoulos, senior research scientist in the Department of Epidemiology, explains the findings of a recent study on social support and viral suppression among young adults living with HIV.
Victor De Gruttola’s storied career celebrated at biostatistics symposium
Members of the Department of Biostatistics recently gathered for a symposium celebrating the 50-year career of Victor De Gruttola, former chair and professor of biostatistics emeritus.
Timing of HIV treatment during pregnancy could affect developmental delays in children
During pregnancy, the timing of when mothers start taking antiretroviral drugs to treat HIV may impact the risk of developmental delays in children, according to a study co-authored by researchers at Harvard Chan School.
Strength in numbers
Octavious Smiley, PhD ’23, is dedicated to helping the next generation of minority students excel in the field of biostatistics.
